Systemic Sclerosis (Scleroderma) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2024 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Systemic Sclerosis (Scleroderma) Clinical Trial Report Overview
A total of 683 systemic sclerosis clinical trials were conducted as of April 2024. The systemic sclerosis clinical trial report provides a comprehensive understanding of the systemic sclerosis clinical trial scenario across regions, and countries (G7 & E7), along with insights into the various phases, trial status, and end points status. The report also includes information about the sponsor type and the prominent sponsors associated with the trials.
Key Regions | · North America
· Europe · Asia-Pacific · Middle East and Africa · South and Central America |
Key Countries | · The US
· Italy · Germany · France · The UK |
Key Sponsor Types | · Company
· Institution · Government |
Leading Sponsors | · Johnson & Johnson
· C. H. Boehringer Sohn AG & Co KG · Bristol-Myers Squibb Co · Sanofi · F. Hoffmann-La Roche Ltd |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Systemic Sclerosis Clinical Trials Segmentation by Regions and Countries
Europe led the systemic sclerosis clinical trials landscape with more than 35% of the clinical trials conducted as of April 2024.
The key regions considered for systemic sclerosis clinical trials analysis are Asia-Pacific, Europe, North America, Middle East and Africa, and South and Central America.
In the country-wise analysis, the US had the highest number of systemic sclerosis clinical trials, as of April 2024. Germany had the highest average patient enrollment of systemic sclerosis clinical trials, during the same time.
G7 countries: Among the G7 (United States, United Kingdom, Germany, France, Italy, Canada, and Japan) countries, Italy had the highest proportion of systemic sclerosis to immunology clinical trials as of April 2024.
E7 countries: Among the E7 (Brazil, Russia, India, China, Mexico, Turkey, and Indonesia) countries, Russia had the highest proportion of systemic sclerosis to immunology clinical trials as of April 2024.
Systemic Sclerosis Clinical Trials Analysis by Regions, 2024 (%)
Buy the Full Report for More Regional Insights into the Systemic Sclerosis Clinical Trials
Download a Free Sample Report
Systemic Sclerosis Clinical Trials Segmentation by Sponsor Types
The key sponsor types for systemic sclerosis clinical trials are company, institution, and the government. As of April 2024, over 54% of systemic sclerosis clinical trials conducted were sponsored by institution sponsor type, followed by the company.
Systemic Sclerosis Clinical Trials Analysis by Sponsor Type, 2024 (%)
Buy the Full Report for More Insights into the Systemic sclerosis Clinical Trials Sponsor Types
Systemic Sclerosis Clinical Trials - Competitive Landscape
In April 2024, Johnson & Johnson conducted the highest number of systemic sclerosis clinical trials.
A few of the leading sponsors for systemic sclerosis clinical trials are:
- Johnson & Johnson
- C. H. Boehringer Sohn AG & Co KG
- Bristol-Myers Squibb Co
- Sanofi
- F. Hoffmann-La Roche Ltd
Systemic Sclerosis Clinical Trials Analysis by Leading Companies, 2024 (%)
Buy Full Report to Know More About the Leading Players of Systemic Sclerosis Clinical Trials
Segments Covered in the Report
Systemic Sclerosis Clinical Trials Regional Outlook (2024)
- Asia-Pacific
- Europe
- North America
- Middle East and Africa
- South and Central America
Systemic Sclerosis Clinical Trials Country Outlook (2024)
- The US
- Italy
- Germany
- France
- The UK
Systemic Sclerosis Clinical Trials Sponsor Type Outlook (2024)
- Company
- Institution
- Government
Scope
- The report provides a snapshot of the global clinical trials landscape.
- The report provides top-level data related to the clinical trials by region, country (G7 & E7), trial status, trial phase, sponsor type, and endpoint status.
- The report reviews the top companies involved and enlists all trials (trial title, phase, and status) of the company.
- The report provides all the unaccomplished trials (terminated, suspended, and withdrawn) with a reason for accomplishment.
- The report provides enrollment trends for the past five years.
- The report provides the latest news for the past three months.
Reasons to Buy
- Assists in formulating key investment strategies.
- Helps in identifying time-saving and cost-efficient locations to conduct clinical trials.
- Provides top-level analysis of the global clinical trials market to help in identifying key business opportunities.
- Helps in understanding trial count and enrollment trends by country in the global therapeutics market.
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended, or withdrawn) trials.
- Facilitates clinical trial assessment of the indication on a global, regional, and country level.
C. H. Boehringer Sohn AG & Co KG
Bristol-Myers Squibb Co
Sanofi
F. Hoffmann-La Roche Ltd
Amgen Inc
GSK plc
Thermo Fisher Scientific Inc
Novartis AG
Pfizer Inc
Table of Contents
Table
Figures
Frequently asked questions
-
Which region accounted for the highest number of systemic sclerosis clinical trials in April 2024?
Europe accounted for the highest number of systemic sclerosis clinical trials as of April 2024.
-
Which country conducted the highest number of systemic sclerosis clinical trials in April 2024?
The US conducted the highest number of systemic sclerosis clinical trials as of April 2024.
-
Which sponsor type was the most prominent in the systemic sclerosis clinical trials in April 2024?
As of April 2024, most of the systemic sclerosis clinical trials conducted were sponsored by institution sponsor type.
-
Which are the leading sponsors of systemic sclerosis clinical trials?
A few of the leading sponsors of systemic sclerosis clinical trials are Johnson & Johnson, C. H. Boehringer Sohn AG & Co KG, Bristol-Myers Squibb Co, Sanofi, and F. Hoffmann-La Roche Ltd, among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.